flu
Roche’s flu drug speeds up recovery in Phase III trial
October 4, 2018Research and Development Roche, drug, flu, pharma, recovery
Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …
More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter
September 12, 2018Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma
Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …
Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines
August 16, 2018Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma
Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …
Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?
July 17, 2018Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma
Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …
CDC U-turns previous decision on AZ’s flu vaccine
February 22, 2018Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical
The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …
Low flu vaccine efficacy may be due to previous immune history, study finds
February 20, 2018Manufacturing and Production, Research and Development H3N2, Vaccine, flu, flue vaccine, influenza, pharma
The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, …
New flu med can destroy influenza virus in one day
February 13, 2018Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical
Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
New vaccine provides universal protection against influenza A, study finds
January 24, 2018Research and Development Georgia State University, Vaccine, flu, influenza, pharma
Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …
Universal flu vaccine receives Google’s financial backing
January 15, 2018Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical
Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …
Seqirus announces £40m UK fill-and-finish flu vaccine facility
November 9, 2017Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus
Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …
Collaboration brings forward potential broad flu cure
October 2, 2017Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …
Newly adopted flu vaccine could save 1,700 lives
September 12, 2017Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus
The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …
Revolutionary patch could offer alternative to flu injections
June 28, 2017Research and Development flu, flu vaccine, patch delivery
A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …
MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use
July 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi pasteur msd, UK, Vaccine, flu, influenza
Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: …
AstraZeneca set to lose out on $80 million after US turns down flu vaccine
June 23, 2016Sales and Marketing AstraZeneca, CDC, flu, flu vaccine
AstraZeneca has confirmed that its influenza vaccine, FluMist Quadrivalent, will not be used in the US during the 2016-17 flu …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
